Abstract

Novel Schiff base ligand was prepared by the condensation of 2,2-(ethylenedioxy)bis(ethylamine) and imidazole-2-carboxaldehyde in a 1:2 ratio, and its complexes with Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), and Cd(II) metal ions were synthesized in a 1:1 ratio. Various methods were used to identify the Schiff base ligand and complexes. Characterization techniques such as infrared, UV, and 1H NMR spectral tests, elemental analysis, molar conductivity, magnetic properties, thermal analysis, BET surface area, and theoretically by DFT were used to help further understanding of the complex structures. For all complexes, the ligand behaved as a neutral tetradentate ligand with NOON donor atoms and spectroscopic studies indicated an octahedral structure. The electrolytic behavior of the complexes was revealed by the molar conductivity measurements. In addition, thermogravimetric analysis was used to investigate the decomposition of the complexes and Schiff base ligand. According to the results obtained, the antibacterial activity of the metal complexes is higher than that of the Schiff base ligand against one or more bacterial species. The results showed that Cd(II) complex exhibits enhanced activity against Aspergillus flavus and Ni(II) complex against Candida albicans than the standard drug ketoconazole. The Mn(II) complex had stronger activity against human breast cancer cell line (MCF-7) than the other complexes. Antiviral drug development is critical in the latest outbreak of a novel coronavirus (SARS-CoV-2). The new coronavirus was screened using molecular docking.Supplementary InformationThe online version contains supplementary material available at 10.1007/s13738-021-02359-w.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call